Annotated Bibliography On Personalized Medicine

Personalized medicine is currently on the running towards becoming one of the leading advancing fields of health care determined by a person’s individual genetic make-up. It enables an understanding of the molecular framework of the human system so as to augment preventive therapeutic strategies. The move from reactive to preventive health care comes about with the implementation of personalized medicine as an alternative to traditional health care practices.

Racial categories play a significant role in healthcare and research, and should not be eliminated. Firstly, studying race advances health care research because it adds a layer of understanding between the doctor and the patient; the researcher and the subject. Race is a real aspect of human life, and ignoring it completely will make a superficial relationship between health care professionals and their patients. By studying the behavior of physicians, a 2010 study concluded “patient race is important to physicians when making decisions about preconception genetic testing and that decision making is influenced by patients’ physical characteristics” (Bonham et al. 2010). Patient race was important to the physicians’ decision making skills.

HC2: With personalized medicine comes many areas of concern, including cost and ethics. It is well known that medical testing of any kind is typically very costly, and personalized medicine is no different. Medical institutions are often slow to adopt new technology and unwilling

The world we live in is advancing more and more every day. We are beginning to exceed boundaries and reach new limits. Science and Technology has come a long way since Copernicus said that the sun was the center of the universe. Science fiction is slowly coming to life. We are building robots that are extremely similar to humans, modifying genes, and creating clones. Authors wrote about these abstract ideas not too long ago, but at the time they seemed far-fetched. Scientific and technological advancement may be for good or for evil. The good side is the advancements in medicine that could limit the risk of a particular disease or even cure one. The potentially bad side is the steps we may take to get there without knowing the long-term effect. In Michael Bess’s article “Blurring the Boundary Between Person and Product,” he discusses the advancement of genetic

There have been inventions that have given hope and inspiration to others. Everyone values medicine and the technology that we currently have. But how far is too far? Medical technology is very economically risky and those that can’t afford it may struggle. Do you think this technology should be open to anyone, whether they are rich or poor? “We have shown through research that providing additional support to vulnerable patients and to their physicians, to provide education, support, and address the unique barriers they face, we can provide all patients the best care and best hope for a cure.” (Freund, 2015). Karen Freund is also one of the research professors that has a lot of experience as well as her interest in

Finding a panacea for cancer will be an arduous task with a very lengthy and discouraging trial and error period. Inevitably there will be some trying hurdles to get past in search of this cancer panacea, but, one that seems to be the most difficult to get passed is the severity and variety of the case presented. Doctors see this as overwhelming and very daunting since they do not want to get a patient’s hopes up if the medicine turns out not to work, or cause things to get worse. If doctors believe they have found this new and astonishing drug that cures all cancer at all stages and they prescribe it but turns out to only make the cancer worse, they will have to live knowing that they hurt all of these people and their families forever. In

Even if doctor and scientist do quality research there can still be flaws in the theories themselves. Doctors need to continually adjust medicine as it evolves and test new theories. The idea of this constant change is paradoxical because point A becomes point B, but by that time point B has already become part C. The reason for this is some people have higher tolerances to medication, therefore the solution to the issue is not always one hundred percent beneficial to all that use them. Some people may not get sick as easily as others because they have stronger immune systems.

Dr. Otis Brawley of Emory University and current Medical Director of the American Cancer Society lead the discussion by creating a historical perspective of “race” and its position, or lack of it, in cancer research and treatment. The concept of “race medicine” was one that held strength in the first three decades of the 20th Century and saw its nadir

Often, with the discovery of knowledge come difficult questions, thorny ethical issues, and unintended consequences. Armed with this new ability to sequence human genes, science grabbed medicine by the hand and charged into uncharted territory. Could we now “personalize” medicine?

Personalized medicine is the breaking age phenomenon of the future; it will identify and manage healthcare problems, through molecular analysis. Personalize medicine is impacting breast and colon cancer treatment, and genetic testing for individuals that inherit cardiac conditions. Americans will benefit from personal medical care, but will ethical issues prevent the medical breakthrough from rising.

It is hard to believe that in a first world country women are more likely to die of cardiovascular disease than men because clinical researchers tend to conduct more health studies on men and then release the research to the public claiming that the studies apply to both genders. Sadly, the problem of women not being equally represented as men in clinical studies is a reality in the United States of America and puts women at risk for their health; however the problem can be fixed by creating awareness, incorporating more females in health research, and creating a better, dedicated Food and Drug Administration (FDA). Each of the three solutions is necessary as they would

Some of these reasons include minorities may not have exposure to participate in clinical trials, there is lack of trust among racial groups, researchers and clinicians don’t target them for inclusion into clinical trials, and lack of understanding about clinical trials. The bill proposal was created to develop and offer strategic plans to increase minority and women research involvement. If we do not see a diverse group of people participating in the clinical trials of all diseases, we will continue to see higher numbers of incidences and mortality among these groups of people Chen, Lara, Dang, Paterniti, and Kelly (2014). NIH would improve the health disparities of minorities and women through their increased participation in clinical

The book The Personalized Medicine Revolution: How Diagnosing and Treating Disease are About to Change Forever is an interesting journey through the evolution of our scientific knowledge and subsequent technologies followed by a final foray into the most current accomplishments in personalized medicine and where it’s going.

Different studies have researched whether molec¬ular variability between patients can anticipate response to standard chemotherapy drugs to facilitate a more personalized approach to chem¬otherapy.

These personal companions are able to monitor every human reaction to physical and emotional stimuli, as well as, how a specific disease process is affecting the different systems of the body, and how medications are systemically treating any disease process. This system will detect disease processes much earlier than is capable at the present time. This information is then transmitted to this global health care network, as previously mentioned, and the data used to better understand disease processes and help to find cures for these diseases. The human genome has also been decoded by computers, for the cost of around one-hundred dollars. With this technology, medical professionals can better understand why some people, and who these people are specifically, are more susceptible to different types of cancer, heart disease, diabetes and so on. These chronic conditions and diseases will be cured and prevented and the larger problem will be mutating viruses and “super bugs”, for which pharmaceutical companies have put very little effort into developing curative or nonresistant medications.